Skip to main content
Tessa NewsLink
Paste a health news link, or browse

Several possible studies

Story checked

Injectable foam prototype could seal deep wounds and help prevent amputations (opens in a new tab)

medicalxpress.com · 2026-10-03

Short answerEvidenceSource

Short answer

Several possible studies

No clear answer.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Several studies could be the source of this story.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Open claim evidence
3

Search result

Several studies could fit.

More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.

Related research

Research nearby

The papers it could be

Nearby papers when the source is unclear.

and 19 more considered

Then inspect each claim

Evidence layer

Claim by claim

What the story asserts. With no source study, there is nothing to check these against.

Claim 1 of 5Not checkedA startup is developing an injectable silicone compound that expands into a soft foam inside deep wounds, with the aim of sealing them and helping prevent amputations and reduce mortality among patients with severe wounds.View evidenceHide evidence

As statedprevent amputations and reducing mortality

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 2 of 5Not checkedThe foam is intended to remove wound fluid (exudate), which may contain harmful bacteria, and to adapt to the geometry of deep, complex wounds.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 3 of 5Not checkedThe technology stems from research at DTU, and AleSac has developed a physical prototype based on that research.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 4 of 5Not checkedIn laboratory tests, AleSac's antibacterial foam was shown to be effective against multiresistant bacteria in less than 120 minutes.View evidenceHide evidence

As statedless than 120 minutes

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Claim 5 of 5Not checkedAleSac has been accepted into the U.S. medtech accelerator program BioLab CATALYST, which the story presents as a step toward future FDA approval and U.S. commercialization.View evidenceHide evidence

Not checked

NewsLink could not identify one source study, so this claim was not compared against a paper.

Finally, the search trail

Method layer

No single source study was found.

NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.

Nearby research

No exact source, but these papers are close.

PubMed, Crossref · 15 candidate papers

Candidate

PROMOTING COMPLEX WOUND HEALING THROUGH THE UTILIZATION OF AN ANTIMICROBIAL SOFT SILICONE FOAM DRESSING

Journal of Wound, Ostomy & Continence Nursing · 2008 · Crossref

Source (opens in a new tab)
Candidate

Silver-Coated Foam with Silicone Interface Outperforms Other Silver Containing Wound Dressings in an In-Vitro Wound Model

Journal of the American College of Surgeons · 2022 · Crossref

Source (opens in a new tab)

And 10 more candidates considered.